Praxis Precision Medicines (PRAX) Revenue (Gross) (2024 - 2025)
Historic Revenue (Gross) for Praxis Precision Medicines (PRAX) over the last 2 years, with Q3 2025 value amounting to $4.4 million.
- Praxis Precision Medicines' Revenue (Gross) fell 1015.23% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.1 million, marking a year-over-year increase of 6634.07%. This contributed to the annual value of $17.3 million for FY2024, which is 46027.13% up from last year.
- Per Praxis Precision Medicines' latest filing, its Revenue (Gross) stood at $4.4 million for Q3 2025, which was down 1015.23% from $4.9 million recorded in Q2 2025.
- Over the past 5 years, Praxis Precision Medicines' Revenue (Gross) peaked at $5.4 million during Q1 2025, and registered a low of $2.3 million during Q1 2024.